Head-to-head comparison of GLP-1/GIP agonists on CVD: A pharmacoepidemiologic analysis of two datasets led by Pamela Lutsey, Ph.D., FAHA, professor with Regents of the University of Minnesota Twin Cities
Amenta F, Cavallotti C, de Rossi M, Bossoni G, Carpi C
A two-way ANOVA comparison evaluating for social novelty treatment interaction between normal C57BL/6J mice and the MIA mice did not detect a significant interaction F( 1, 24 ) = 0.43
Possible role of the gut microbiotabrain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
Researchers have attempted to establish the associations between serum IGFs levels and cancer risk
But when plant cells go to the gut, the bacteria there release enzymes to break down their cell walls. Their approach also avoids a step in the production of conventional GLP-1 receptor agoniststhe post-translational modifications, or chemical changes made to peptides after synthesis, required to make them functional